Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Jinhua Qinggan Granules for acute upper respiratory tract infection (wind-heat syndrome)
CTR20244296Phase 3Active
- Sponsor
- Juxiechang
- Start
- Apr 2025
- Countries
- 1
01
Overview
A Phase 3 trial of jinhua qinggan granules in upper respiratory infection (URI), sponsored by Juxiechang. Started Apr 2025; status: active.
02
Drugs
jinhua qinggan granules
03
Conditions
upper respiratory infection (URI)
Beyond the preview
Go deeper on CTR20244296.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20244296.